HDAC inhibition by valproic acid has been demonstrated to upregulate TRAIL and its receptor DR5 in acute myeloid leukemia cells and thereby induces caspase-8 activation [19]. The gene discussed is TNFRSF10B; the disease is acute myeloid leukemia.